To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

and Inclusion

The Chris Elliott Fund dba EndBrainCancer Initiative is committed to a diverse, inclusive, and equitable environment where all board members, staff, volunteers, patients, caregivers, and other members of our community feel respected and valued regardless of gender, age, race, ethnicity, national origin, sexual orientation or identity, disability, education, socioeconomic status, or any other bias.

We’re committed to being nondiscriminatory and providing equal opportunities for employment, volunteering, and advancement in all areas of our work.

We respect the value that diverse life experiences bring to our board and leadership team and we strive to listen to their views and give them value.

We’re committed to modeling diversity, equity, and inclusion and maintaining fair and equal treatment for all.
Our board’s philosophy on our goals to provide informed leadership for diversity, equity, and inclusion include:
  • We will strive to see diversity, equity, and inclusion in connection with our vision and mission for the benefit of those we serve.
  • We aim to recognize and address inequities in our policies, programs, and services.
  • We will update and document progress on our diversity, equity, and inclusion practices.
  • We promise to investigate underlying assumptions that interfere with our diversity policy.
  • We commit to advocating for systemic inequities that impact our work at the board level and address it according to this policy and in accordance with our mission.
  • We commit to challenging commonly accepted notions about what constitutes strong leadership within our organization.
  • We commit to being transparent about diversity in all our interactions.
  • We will dedicate our time and resources to expanding greater diversity within our board and leadership positions.
  • We commit to leading with respect and tolerance and we encourage all employees and volunteers to express this in their work within our organization.
Chris Elliott Fund dba EndBrainCancer Initiative agrees to abide by the following action items to promote diversity, equity, and inclusion in our work:
  1. We will create new learning opportunities and formal, transparent policies as we strive for cultural competency throughout our organization.
  2. We will strive to conduct or identify research related to equity so that we can make progress in the area of diversity, equity, and inclusion and we’ll share our findings publicly on our website.
  3. We will take action to improve diversity, equity, and inclusion in our board and leadership positions.
  4. We will identify resources for our underrepresented constituents by networking with other organizations that are also committed to efforts for diversity, equity, and inclusion.
  5. We will develop internal resources that demonstrate our commitment to diversity, equity, and inclusion and present them to our members and members of our community.
  6. We will develop a system to create awareness and address biases during our recruiting, hiring, and evaluating processes.
  7. We will train our personnel to be responsible for orienting, onboarding, and training our staff and volunteers on equitable practices.
  8. We will be transparent about the salary range for public job descriptions.
  9. We will advocate for public and private policies in the public sector that promote diversity, equity, and inclusion and we will challenge systems and policies that describe inequity, disparity, and oppression. 
Policy approved by the Board of Directors, September 2021


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram